304 related articles for article (PubMed ID: 32743611)
1. Cell type-specific immune dysregulation in severely ill COVID-19 patients.
Yao C; Bora SA; Parimon T; Zaman T; Friedman OA; Palatinus JA; Surapaneni NS; Matusov YP; Chiang GC; Kassar AG; Patel N; Green CE; Aziz AW; Suri H; Suda J; Lopez AA; Martins GA; Stripp BR; Gharib SA; Goodridge HS; Chen P
medRxiv; 2020 Jul; ():. PubMed ID: 32743611
[TBL] [Abstract][Full Text] [Related]
2. Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients.
Yao C; Bora SA; Parimon T; Zaman T; Friedman OA; Palatinus JA; Surapaneni NS; Matusov YP; Cerro Chiang G; Kassar AG; Patel N; Green CER; Aziz AW; Suri H; Suda J; Lopez AA; Martins GA; Stripp BR; Gharib SA; Goodridge HS; Chen P
Cell Rep; 2021 Jan; 34(1):108590. PubMed ID: 33357411
[TBL] [Abstract][Full Text] [Related]
3. Documenting the immune response in patients with COVID-19-induced acute respiratory distress syndrome.
Lu J; Zeng X; Lu W; Feng J; Yang Y; Wei Y; Chen Y; Zhang J; Pinhu L
Front Cell Dev Biol; 2023; 11():1207960. PubMed ID: 37363730
[No Abstract] [Full Text] [Related]
4. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
[TBL] [Abstract][Full Text] [Related]
6. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.
Eskandarian Boroujeni M; Sekrecka A; Antonczyk A; Hassani S; Sekrecki M; Nowicka H; Lopacinska N; Olya A; Kluzek K; Wesoly J; Bluyssen HAR
Front Immunol; 2022; 13():888897. PubMed ID: 35663932
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
9. Parallel Dysregulated Immune Response in Severe Forms of COVID-19 and Bacterial Sepsis via Single-Cell Transcriptome Sequencing.
Garduno A; Martinez GS; Ostadgavahi AT; Kelvin D; Cusack R; Martin-Loeches I
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979757
[TBL] [Abstract][Full Text] [Related]
10. pcMSC Modulates Immune Dysregulation in Patients With COVID-19-Induced Refractory Acute Lung Injury.
Chen MC; Lai KS; Chien KL; Teng ST; Lin YR; Chao W; Lee MJ; Wei PL; Huang YH; Kuo HP; Weng CM; Chou CL
Front Immunol; 2022; 13():871828. PubMed ID: 35585988
[TBL] [Abstract][Full Text] [Related]
11. CCR2 Signaling Restricts SARS-CoV-2 Infection.
Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
[TBL] [Abstract][Full Text] [Related]
12. Bifurcated monocyte states are predictive of mortality in severe COVID-19.
Cillo AR; Somasundaram A; Shan F; Cardello C; Workman CJ; Kitsios GD; Ruffin A; Kunning S; Lampenfeld C; Onkar S; Grebinoski S; Deshmukh G; Methe B; Liu C; Nambulli S; Andrews L; Duprex WP; Joglekar AV; Benos PV; Ray P; Ray A; McVerry BJ; Zhang Y; Lee JS; Das J; Singh H; Morris A; Bruno TC; Vignali DAA
bioRxiv; 2021 Feb; ():. PubMed ID: 33594364
[TBL] [Abstract][Full Text] [Related]
13. Immune characteristics of kidney transplant recipients with acute respiratory distress syndrome induced by COVID-19 at single-cell resolution.
Lu J; Chen Y; Zhou K; Ling Y; Qin Q; Lu W; Qin L; Mou C; Zhang J; Zheng X; Qin K
Respir Res; 2024 Jan; 25(1):34. PubMed ID: 38238762
[TBL] [Abstract][Full Text] [Related]
14. Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome.
Hue S; Beldi-Ferchiou A; Bendib I; Surenaud M; Fourati S; Frapard T; Rivoal S; Razazi K; Carteaux G; Delfau-Larue MH; Mekontso-Dessap A; Audureau E; de Prost N
Am J Respir Crit Care Med; 2020 Dec; 202(11):1509-1519. PubMed ID: 32866033
[No Abstract] [Full Text] [Related]
15. Repressed Ang 1-7 in COVID-19 Is Inversely Associated with Inflammation and Coagulation.
Carpenter RM; Young MK; Petri WAO; Lyons GR; Gilchrist C; Carey RM; Petri WA
mSphere; 2022 Aug; 7(4):e0022022. PubMed ID: 35913134
[TBL] [Abstract][Full Text] [Related]
16. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.
Lupu L; Palmer A; Huber-Lang M
Front Immunol; 2020; 11():584514. PubMed ID: 33101314
[TBL] [Abstract][Full Text] [Related]
17. Early spontaneous breathing for acute respiratory distress syndrome in individuals with COVID-19.
Hohmann F; Wedekind L; Grundeis F; Dickel S; Frank J; Golinski M; Griesel M; Grimm C; Herchenhahn C; Kramer A; Metzendorf MI; Moerer O; Olbrich N; Thieme V; Vieler A; Fichtner F; Burns J; Laudi S
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD015077. PubMed ID: 35767435
[TBL] [Abstract][Full Text] [Related]
18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
19. Disruption of the CCL5/RANTES-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19.
Patterson BK; Seethamraju H; Dhody K; Corley MJ; Kazempour K; Lalezari JP; Pang AP; Sugai C; Francisco EB; Pise A; Rodrigues H; Ryou M; Wu HL; Webb GM; Park BS; Kelly S; Pourhassan N; Lelic A; Kdouh L; Herrera M; Hall E; Aklin E; Ndhlovu L; Sacha JB
medRxiv; 2020 May; ():. PubMed ID: 32511656
[TBL] [Abstract][Full Text] [Related]
20. SARS - CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis).
Ietto G
Med Hypotheses; 2020 Aug; 141():109779. PubMed ID: 32387756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
